No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position and insiders have been net selling.
Top-trader positions in DHX could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Aug 5, 2026
Period ending
Jun 30, 2026
Earnings per share
$0.05 expected
Revenue
Financial statements: Alpha Vantage
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | $0.08 / $0.05Alpha Vantage | +$0.03 beat | $31.3M No estimate | Unavailable |
| Mar 31, 2026 | May 5, 2026 | $0.08 / $0.03Alpha Vantage | +$0.05 beat | $29.7M No estimate | Unavailable |
| Dec 31, 2025 | Feb 4, 2026 | $0.09 / $0.06Alpha Vantage | +$0.03 beat | $31.4M No estimate | Unavailable |
| Sep 30, 2025 | Nov 10, 2025 | $0.09 / $0.04Alpha Vantage | +$0.05 beat | $32.1M No estimate | Unavailable |
| Jun 30, 2025 | Aug 6, 2025 | $0.07 / $0.01Alpha Vantage | +$0.06 beat | $32.0M No estimate | Unavailable |
| Mar 31, 2025 | May 7, 2025 | $0.04 / $0.01Alpha Vantage | +$0.03 beat | $32.3M No estimate | Unavailable |
| Dec 31, 2024 | Feb 5, 2025 | $0.07 / $0.02Alpha Vantage | +$0.05 beat | $34.8M No estimate | Unavailable |
| Sep 30, 2024 | Nov 12, 2024 | $0.05 / $0.01Alpha Vantage | +$0.04 beat | $35.3M No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $32.1M | $31.4M | $29.7M | $31.3M |
| Cost of what it sold | $4.6M | $782.0K | $4.8M | $6.3M |
| Gross profit | $27.5M | $30.6M | $24.9M | $25.0M |
| What it spent | ||||
| Research and development | $2.9M | $3.0M | $3.1M | $2.9M |
| Sales and admin | $7.0M | $6.4M | $6.8M | $6.3M |
| Other operating costs | $22.2M | $22.2M | $12.0M | $12.0M |
| Total operating expenses | $32.0M | $31.5M | $21.9M | $21.2M |
| What was left | ||||
| Operating profit | -$4.5M | -$956.0K | $3.1M | $3.8M |
| Interest on debt | $614.0K | $566.0K | $553.0K | $687.0K |
| Profit before tax | -$5.0M | $1.8M | $2.5M | $3.1M |
| Tax | -$772.0K | $800.0K | $956.0K | $511.0K |
| Net profit | -$4.3M | $1.4M | $1.5M | $2.6M |
| EBITDA | -$939.0K | $6.1M | $6.1M | $6.6M |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace